Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Feb;21(2):239–241. doi: 10.1111/j.1365-2125.1986.tb05183.x

Arbaprostil (15(R)-15-methyl PGE2): lack of effect on theophylline metabolism.

S B Reele, A Euler, J McEvers, C Metzler
PMCID: PMC1400902  PMID: 3954940

Full text

PDF
239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang K. C., Bell T. D., Lauer B. A., Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet. 1978 May 27;1(8074):1132–1133. doi: 10.1016/S0140-6736(78)90305-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Conlon P. F., Grambau G. R., Johnson C. E., Weg J. G. Effect of intravenous furosemide on serum theophylline concentration. Am J Hosp Pharm. 1981 Sep;38(9):1345–1347. [PubMed] [Google Scholar]
  3. Eaton M. L., Green B. A., Church T. R., McGowan T., Niewoehner D. E. Efficacy of theophylline in "irreversible" airflow obstruction. Ann Intern Med. 1980 Jun;92(6):758–761. doi: 10.7326/0003-4819-92-6-758. [DOI] [PubMed] [Google Scholar]
  4. Gilbert D. A., Surawicz C. M., Silverstein F. E., Weinberg C. R., Saunders D. R., Feld A. D., Sanford R. L., Bergman D., Washington P. Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: an endoscopic study. Gastroenterology. 1984 Feb;86(2):339–345. [PubMed] [Google Scholar]
  5. Hunt S. N., Jusko W. J., Yurchak A. M. Effect of smoking on theophylline disposition. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):546–551. doi: 10.1002/cpt1976195part1546. [DOI] [PubMed] [Google Scholar]
  6. Jackson J. E., Powell J. R., Wandell M., Bentley J., Dorr R. Cimetidine decreases theophylline clearance. Am Rev Respir Dis. 1981 Jun;123(6):615–617. doi: 10.1164/arrd.1981.123.6.615. [DOI] [PubMed] [Google Scholar]
  7. Jusko W. J., Schentag J. J., Clark J. H., Gardner M., Yurchak A. M. Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clin Pharmacol Ther. 1978 Oct;24(4):405–410. [PubMed] [Google Scholar]
  8. Kollberg B., Nordemar R., Johansson C. Gastrointestinal protection by low-dose oral prostaglandin E2 in rheumatic diseases. Scand J Gastroenterol. 1981;16(8):1005–1008. doi: 10.3109/00365528109181019. [DOI] [PubMed] [Google Scholar]
  9. Konturek S. J., Kwiecień N., Swierczek J., Oleksy J., Sito E., Robert A. Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man. Gastroenterology. 1976 May;70(5 PT1):683–687. [PubMed] [Google Scholar]
  10. Landay R. A., Gonzalez M. A., Taylor J. C. Effect of phenobarbital on theophylline disposition. J Allergy Clin Immunol. 1978 Jul;62(1):27–29. doi: 10.1016/0091-6749(78)90068-4. [DOI] [PubMed] [Google Scholar]
  11. Mangione A., Imhoff T. E., Lee R. V., Shum L. Y., Jusko W. J. Pharmacokinetics of theophylline in hepatic disease. Chest. 1978 May;73(5):616–622. doi: 10.1378/chest.73.5.616. [DOI] [PubMed] [Google Scholar]
  12. Peterson W., Feldman M., Taylor I., Bremer M. The effect of 15(R)-15-methyl prostaglandin E2 on meal-stimulated gastric acid secretion, serum gastrin, and pancreatic polypeptide in duodenal ulcer patients. Dig Dis Sci. 1979 May;24(5):381–384. doi: 10.1007/BF01297125. [DOI] [PubMed] [Google Scholar]
  13. Piafsky K. M., Sitar D. S., Rangno R. E., Ogilvie R. I. Theophylline disposition in patients with hepatic cirrhosis. N Engl J Med. 1977 Jun 30;296(26):1495–1497. doi: 10.1056/NEJM197706302962603. [DOI] [PubMed] [Google Scholar]
  14. Piafsky K. M., Sitar D. S., Rangno R. E., Ogilvie R. I. Theophylline kinetics in acute pulmonary edema. Clin Pharmacol Ther. 1977 Mar;21(3):310–316. doi: 10.1002/cpt1977213310. [DOI] [PubMed] [Google Scholar]
  15. Prince R. A., Wing D. S., Weinberger M. M., Hendeles L. S., Riegelman S. Effect of erythromycin on theophylline kinetics. J Allergy Clin Immunol. 1981 Dec;68(6):427–431. doi: 10.1016/0091-6749(81)90196-2. [DOI] [PubMed] [Google Scholar]
  16. Renton K. W., Gray J. D., Hung O. R. Depression of theophylline elimination by erythromycin. Clin Pharmacol Ther. 1981 Sep;30(3):422–426. doi: 10.1038/clpt.1981.182. [DOI] [PubMed] [Google Scholar]
  17. Robert A., Kane G., Reele S. B. Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally. Gut. 1981 Sep;22(9):728–731. doi: 10.1136/gut.22.9.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Robert A., Schultz J. R., Nezamis J. E., Lancaster C. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration. Gastroenterology. 1976 Mar;70(3):359–370. [PubMed] [Google Scholar]
  19. Roberts R. K., Grice J., Wood L., Petroff V., McGuffie C. Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology. 1981 Jul;81(1):19–21. [PubMed] [Google Scholar]
  20. Szczeklik J., Szczeklik A., Nizankowski R. Haemodynamic changes induced by prostacyclin in man. Br Heart J. 1980 Sep;44(3):254–258. doi: 10.1136/hrt.44.3.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Thayssen P., Secher N. J., Arnsbo P. Systolic time intervals and haemodynamic changes during intravenous infusion of prostaglandins F2 alpha and E2. Br Heart J. 1981 Apr;45(4):447–456. doi: 10.1136/hrt.45.4.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vantrappen G., Janssens J., Popiela T., Kulig J., Tytgat G. N., Huibregtse K., Lambert R., Pauchard J. P., Robert A. Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study. Gastroenterology. 1982 Aug;83(2):357–363. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES